Guardant Health, Inc., a leading precision oncology company, announced positive results from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode),...
Veracyte, Inc. announced that findings demonstrating the strong real-world performance of the Afirma Genomic Sequencing Classifier (GSC) were published in The Journal of Clinical...
Alexis Bio, a private regenerative medicine company, announced that realSKIN™ is the first live cell xenotransplant product to be designated as a Regenerative Medicine...
